An_DT
acute_JJ
myeloid_JJ
leukemia_NN
gene_NN
,_,
AML1_NN
,_,
regulates_VBZ
transcriptional_JJ
activation_NN
and_CC
hemopoietic_JJ
myeloid_JJ
cell_NN
differentiation_NN
antagonistically_RB
by_IN
two_CD
alternative_JJ
spliced_VBN
forms_NNS
._.

The_DT
AML1_NN
gene_NN
on_IN
chromosome_NN
21_CD
is_VBZ
disrupted_VBN
in_IN
the_DT
-LRB-_-LRB-
8_CD
;_:
21_CD
-RRB-_-RRB-
-LRB-_-LRB-
q22_NN
;_:
q22_NN
-RRB-_-RRB-
and_CC
-LRB-_-LRB-
3_CD
;_:
21_CD
-RRB-_-RRB-
-LRB-_-LRB-
q26_NN
;_:
q22_NN
-RRB-_-RRB-
translocations_NNS
associated_VBN
with_IN
myelogenous_JJ
leukemias_NNS
and_CC
encodes_VBZ
a_DT
DNA-binding_JJ
protein_NN
._.

From_IN
AML1_NN
gene_NN
,_,
two_CD
representative_JJ
forms_NNS
of_IN
proteins_NNS
,_,
AML1a_NN
and_CC
AML1b_NN
,_,
are_VBP
produced_VBN
by_IN
an_DT
alternative_JJ
splicing_NN
._.

Both_DT
forms_NNS
have_VBP
DNA-binding_JJ
domain_NN
,_,
but_CC
AML1a_NN
lacks_VBZ
a_DT
putative_JJ
transcriptional_JJ
activation_NN
domain_NN
which_WDT
AML1b_NN
has_VBZ
._.

Here_RB
we_PRP
demonstrate_VBP
that_IN
AML1a_NN
,_,
which_WDT
solely_RB
has_VBZ
no_DT
effects_NNS
as_IN
a_DT
transcriptional_JJ
regulator_NN
,_,
dominantly_RB
suppresses_VBZ
transcriptional_JJ
activation_NN
by_IN
AML1b_NN
,_,
and_CC
that_IN
AML1a_NN
exhibits_VBZ
the_DT
higher_JJR
affinity_NN
for_IN
DNA-binding_NN
than_IN
AML1b_NN
._.

Furthermore_RB
a_DT
dominant_JJ
negative_JJ
form_NN
of_IN
AML1_NN
,_,
AML1a_NN
,_,
totally_RB
suppressed_VBD
granulocytic_JJ
differentiation_NN
otherwise_RB
induced_VBN
by_IN
granulocyte_NN
colony-stimulating_JJ
factor_NN
when_WRB
AML1a_NN
was_VBD
overexpressed_VBN
in_IN
32Dc13_NN
murine_JJ
myeloid_JJ
cells_NNS
._.

Such_JJ
differentiation_NN
block_NN
by_IN
AML1a_NN
was_VBD
canceled_VBN
by_IN
the_DT
concomitant_JJ
overexpression_NN
of_IN
AML1b_NN
._.

These_DT
data_NNS
strongly_RB
suggest_VBP
that_IN
a_DT
transcriptionally_RB
active_JJ
form_NN
of_IN
AML1_NN
is_VBZ
essential_JJ
for_IN
the_DT
myeloid_JJ
cell_NN
differentiation_NN
._.

In_IN
addition_NN
,_,
we_PRP
observed_VBD
an_DT
altered_JJ
expression_NN
level_NN
of_IN
AML1_NN
along_IN
with_IN
the_DT
myeloid_JJ
differentiation_NN
in_IN
several_JJ
hemopoietic_JJ
cell_NN
lines_NNS
._.

In_IN
these_DT
cases_NNS
,_,
at_IN
least_JJS
,_,
the_DT
AML1_NN
expression_NN
level_NN
is_VBZ
a_DT
potential_JJ
regulator_NN
for_IN
myeloid_JJ
cell_NN
differentiation_NN
._.

